INFU News and Press, InfuSystems Holdings Inc. From 11/06/23

2023-11-06 10:30:08 ET Major earnings expected before the bell on Tuesday include: Air Products and Chemicals ( APD ) Datadog ( DDOG ) D.R. Horton ( DHI ) Emerson Electric ( EMR ) Uber Technologies ( UBER ) For further details see: Notable...

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufactu...

2023-09-13 07:18:38 ET Summary CellerateRX was approved to be sold in over 1200 new locations. BIASURGE was approved by the FDA and is set to launch commercially in Q4. TEXAGEN sales growing extremely fast (86% QoQ). Second supplier of ALLOCYTE coming online to s...

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, C...

2023-08-07 23:20:00 ET Summary InfuSystem reported mixed results for its 2Q23 earnings, with revenue beating expectations but a lower adjusted EBITDA margin. The company's revenue in the first half of the year exceeded initial guidance, indicating strong business growth. Despi...

2023-08-04 09:33:01 ET InfuSystem Holdings, Inc. (INFU) Q2 2023 Earnings Conference Call August 3, 2023 9:00 a.m. ET Company Participants Joe Dorame - Managing Partner Richard DiIorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lac...

2023-08-03 06:45:12 ET InfuSystem press release ( NYSE: INFU ): Q2 GAAP EPS of $0.02 beats by $0.02 . Revenue of $31.7M (+17.2% Y/Y) beats by $2.6M . Adjusted earnings before interest, income taxes, depreciation, and amortization was $5.8 million, an increase o...

Record Net Revenues of $31.7 million Representing 17% Growth From the Prior Year InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable m...

2023-08-02 14:30:15 ET InfuSystem ( NYSE: INFU ) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open. The consensus EPS Estimate is $0.08 vs -$0.01 in 2Q22 and the consensus Revenue Estimate is $29.1M (+7.6% Y/Y). Over the last...

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufactu...